Publications by authors named "Javier Cid-Ruzafa"

Claim this Profile
E
Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain.
Carlos Escobar, Beatriz Palacios, Victoria Gonzalez, Martín Gutiérrez, Mai Duong, Javier Cid-Ruzafa

BMC Health Serv Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations when planning and conducting large global observational studies: Experience from the DISCOVER study of patients with type 2 diabetes.
Pernilla Aarskog, Javier Cid-Ruzafa, Hungta Chen, Peter Fenici, Larisa Ramirez Gutierrez

Prim Care Diabetes· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction.
Carlos Escobar, Beatriz Palacios, Victoria Gonzalez, Martín Gutiérrez, Mai Duong, Javier Cid-Ruzafa

J Clin Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Bernard H Charbonnel, Hungta Chen, Javier Cid-Ruzafa, Andrew Cooper, Peter Fenici

Diabetes Obes Metab· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Epidemiology Model for Estimating the Numbers of US Patients With Multiple Myeloma by Line of Therapy and Treatment Exposure.
Andreas Nikolaou, Cosmina Hogea, Yevgeniy Samyshkin, Eric M Maiese, Leah Sansbury, Javier Cid-Ruzafa

Value Health· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain.
Carlos Escobar, Beatriz Palacios, Luis Varela, Martín Gutiérrez, Mai Duong, Javier Cid-Ruzafa

BMC Health Serv Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain.
Carlos Escobar, Beatriz Palacios, Luis Varela, Martín Gutiérrez, Mai Duong, Javier Cid-Ruzafa

J Clin Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linaclotide utilization and potential for off-label use and misuse in three European countries.
Javier Cid-Ruzafa, Brian E Lacy, Anna Schultze, Mai Duong, Yi Lu

Therap Adv Gastroenterol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study.
Marília B Gomes, Fengming Tang, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici

Front Endocrinol (Lausanne)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Suzanne V Arnold, Kamlesh Khunti, Fengming Tang, Hungta Chen, Javier Cid-Ruzafa

Am Heart J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study.
Antonio Nicolucci, Hungta Chen, Javier Cid-Ruzafa, Andrew Cooper, Peter Fenici

Diabetes Res Clin Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes and heart failure: insights from the global DISCOVER study.
Suzanne V Arnold, Kamlesh Khunti, Fabrice Bonnet, Bernard Charbonnel, Hungta Chen, Javier Cid-Ruzafa

ESC Heart Fail· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.
Krishna K Patel, Marilia B Gomes, Bernard Charbonnel, Hungta Chen, Javier Cid-Ruzafa

Diabetes Obes Metab· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme.
Kamlesh Khunti, Marilia B Gomes, Mikhail Kosiborod, Antonio Nicolucci, Stuart Pocock, Javier Cid-Ruzafa

BMJ Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study.
Wolfgang Rathmann, Bernard Charbonnel, Marília B Gomes, Niklas Hammar, Kamlesh Khunti, Javier Cid-Ruzafa

Diabetes Res Clin Pract· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.
Kamlesh Khunti, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Marilia B Gomes

Diabetes Obes Metab· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme.
Antonio Nicolucci, Bernard Charbonnel, Marília B Gomes, Kamlesh Khunti, Mikhail Kosiborod, Javier Cid-Ruzafa

Diabetes Obes Metab· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication.
Javier Cid Ruzafa, Sinna Pilgaard Ulrichsen, Dimitri Bennett, Vera Ehrenstein

Drugs Real World Outcomes· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study.
Marilia B Gomes, Wolfgang Rathmann, Bernard Charbonnel, Kamlesh Khunti, Mikhail Kosiborod, Javier Cid-Ruzafa

Diabetes Res Clin Pract· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Mikhail Kosiborod, Marilia B Gomes, Antonio Nicolucci, Stuart Pocock, Wolfgang Rathmann, Javier Cid-Ruzafa

Cardiovasc Diabetol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Kamlesh Khunti, Thomas R Godec, Jesús Medina, Laura Garcia-Alvarez, Josh Hiller, Javier Cid-Ruzafa

Diabetes Obes Metab· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of characteristics of post-authorisation studies registered on the ENCePP EU PAS Register.
Robert Carroll, Sreeram V Ramagopalan, Javier Cid-Ruzafa, Dimitra Lambrelli, Laura McDonald

F1000Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model.
Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F Baggaley, Pamela Leighton, Winifred Werther

Pharmacoepidemiol Drug Saf· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihyperglycaemic treatment patterns, observed glycaemic control and determinants of treatment change among patients with type 2 diabetes in the United Kingdom primary care: a retrospective cohort study.
Andrew Maguire, Beth D Mitchell, Javier Cid Ruzafa

BMC Endocr Disord· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model.
Justyna M Starczewska Amelio, Javier Cid Ruzafa, Kamal Desai, Spiros Tzivelekis, Dominic Muston

BMC Cancer· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis